Physician profile
Arthur Flatau
NPI 1023184041
$647.71
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $250 · 2020: $113 · 2021: $184 · 2022: $102.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $218.81 | 2019-2022 | |
| Medtronic Vascular, INC. | $105.16 | 2019-2020 | |
| Boston Scientific Corporation | $62.73 | 2021 | |
| Cardinal Health 200 LLC | $50.77 | 2019-2020 | |
| Inari Medical, INC. | $47.40 | 2020 | |
| Philips North America LLC | $43.61 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $31.85 | 2020 | |
| Cardiva Medical, INC. | $26.99 | 2021-2022 | |
| Bard Peripheral Vascular, INC. | $23.36 | 2021 | |
| Cordis US Corp. | $22.92 | 2022 | |
| Medtronic, INC. | $14.11 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arthur Flatau listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.